Novartis India net profit leaps over 5-fold to Rs 4.39 crore in Q1
New Delhi: Drug firm Novartis India on Thursday reported over five-fold jump in net profit at Rs 4.39 crore for the quarter ended June 30, 2020, mainly on account of reduction in expenses.The company had posted a net profit of Rs 79 lakh in the corresponding period of previous fiscal, Novartis India said in a filing to the BSE.Revenue from operations stood at Rs 92.46 crore in the quarter...
New Delhi: Drug firm Novartis India on Thursday reported over five-fold jump in net profit at Rs 4.39 crore for the quarter ended June 30, 2020, mainly on account of reduction in expenses.
The company had posted a net profit of Rs 79 lakh in the corresponding period of previous fiscal, Novartis India said in a filing to the BSE.
Revenue from operations stood at Rs 92.46 crore in the quarter under consideration as against Rs 109.31 crore in the same quarter a year ago, it added.
Total expenses of the company were at Rs 93 crore in the quarter under review as against Rs 118.89 crore in April-June quarter a year ago.
Shares of Novartis India on Thursday closed 0.95 per cent lower at Rs 644.40 on the BSE.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd